Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-14-012066
Filing Date
2014-03-11
Accepted
2014-03-11 15:24:58
Documents
1
Period of Report
2014-03-07

Document Format Files

Seq Description Document Type Size
1 MARCH 7, 2014 OPTION EXERCISE AND SALE rrd405241.html 4  
1 MARCH 7, 2014 OPTION EXERCISE AND SALE rrd405241.xml 4 10987
  Complete submission text file 0001181431-14-012066.txt   12378
Mailing Address ALLOS THERAPEUTICS, INC. 11080 CIRCLEPOINT ROAD, SUITE 200 WESTMINSTER CO 80020
Business Address
EDWARDS MARK G (Reporting) CIK: 0001190429 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35068 | Film No.: 14684027

Mailing Address 351 GALVESTON DRIVE REDWOOD CITY CA 94063
Business Address 351 GALVESTON DRIVE REDWOOD CITY CA 94063 650-216-3500
ACELRX PHARMACEUTICALS INC (Issuer) CIK: 0001427925 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations